PN
Precision Neuroscience Corp
SEC filingOther Health Care · New York, NY
Amount raised$250Msold at filing
Total offeringNot stated
Investors in the raise46count reported to the SEC
FiledSep 28, 2026first sale Sep 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael MagerExecutive Officer, Director
Howard MorganDirector
Ravi MehtaDirector
Michael GollerDirector
Craig MermelExecutive Officer, Director
Konstantinos AlatarisExecutive Officer, Director
Benjamin RapoportExecutive Officer, Director
Stephen BiggarDirector
Michael KaswanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.